Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Toussirot

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Presse Medicale (Paris, France : 1983)|May 20, 1995
[Rheumatoid arthritis: its relationship with HLA DR molecules]E Toussirot, D Wendling
Clinical and Experimental Rheumatology|May 1, 1997
Crohn's disease associated with seropositive rheumatoid arthritisE Toussirot, D Wendling
Expert Opinion on Investigational Drugs|December 16, 2000
Therapeutic advances in ankylosing spondylitisE Toussirot, D Wendling
Revue Du Rhumatisme (English Ed.)|May 26, 1999
TNF-alpha-targeted therapy in rheumatoid arthritisD Wendling, E Toussirot
Presse Medicale (Paris, France : 1983)|April 27, 1996
[Osteoporosis in ankylosing spondylitis]E Toussirot, D Wendling
Drugs|August 26, 1998
Current guidelines for the drug treatment of ankylosing spondylitisE Toussirot, D Wendling
La Revue De Medecine Interne|June 1, 2010
[TNFα blocking agents and sarcoidosis: an update]E Toussirot, E Pertuiset
La Revue De Medecine Interne|June 20, 2006
[The immunogenetics of ankylosing spondylitis]E Toussirot, D Wendling
Clinical and Experimental Rheumatology|December 28, 1999
Methotrexate-induced hyperpigmentation in a rheumatoid arthritis patientE Toussirot, D Wendling
Clinical Rheumatology|May 11, 2001
Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogueE Toussirot, D Wendling
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Presse Medicale (Paris, France : 1983)|May 20, 1995
[Rheumatoid arthritis: its relationship with HLA DR molecules]E Toussirot, D Wendling
Clinical and Experimental Rheumatology|May 1, 1997
Crohn's disease associated with seropositive rheumatoid arthritisE Toussirot, D Wendling
Expert Opinion on Investigational Drugs|December 16, 2000
Therapeutic advances in ankylosing spondylitisE Toussirot, D Wendling
Revue Du Rhumatisme (English Ed.)|May 26, 1999
TNF-alpha-targeted therapy in rheumatoid arthritisD Wendling, E Toussirot
Presse Medicale (Paris, France : 1983)|April 27, 1996
[Osteoporosis in ankylosing spondylitis]E Toussirot, D Wendling
Drugs|August 26, 1998
Current guidelines for the drug treatment of ankylosing spondylitisE Toussirot, D Wendling
La Revue De Medecine Interne|June 1, 2010
[TNFα blocking agents and sarcoidosis: an update]E Toussirot, E Pertuiset
La Revue De Medecine Interne|June 20, 2006
[The immunogenetics of ankylosing spondylitis]E Toussirot, D Wendling
Clinical and Experimental Rheumatology|December 28, 1999
Methotrexate-induced hyperpigmentation in a rheumatoid arthritis patientE Toussirot, D Wendling
Clinical Rheumatology|May 11, 2001
Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogueE Toussirot, D Wendling
Pageof 11